# A Clinical Trial to Assess the Efficacy and Tolerance of a Berberine-based Nutraceutical Formula to Aid Blood Sugar Regulation and Metabolism

> **NCT06700915** · NA · RECRUITING · sponsor: **Ultimate International, Inc.** · enrollment: 80 (estimated)

## Conditions studied

- Metabolism Disorder
- Nutraceutical

## Interventions

- **DIETARY_SUPPLEMENT:** Diaberine
- **DIETARY_SUPPLEMENT:** Placebo Capsule

## Key facts

- **NCT ID:** NCT06700915
- **Lead sponsor:** Ultimate International, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-03
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-05-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06700915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06700915, "A Clinical Trial to Assess the Efficacy and Tolerance of a Berberine-based Nutraceutical Formula to Aid Blood Sugar Regulation and Metabolism". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06700915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*